Drawing for C

USPTO serial 79412512

C

Reviewed by CopyMark Law Group

Reg. 8418070Status 700Registered
Filing date
Status date
Registration date
Sep 1, 2026
Examiner
BROWN, TINA
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with C?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Miriam D. Trudell

Miriam D. Trudell Davis Graham & Stubbs LLP3400 Walnut Street, Suite 700Denver, CO 80205United States

Goods and services

ClassDescriptionStatusFirst use
005Sanitary preparations and articles, namely, sanitary sterilizing preparations, sanitary napkins, sanitary pads; pharmaceutical and medicinal products, namely, pharmaceutical preparations for the treatment of nipple irritation and soreness in breastfeeding women; medicinal herbs, medicinal preparations for the treatment of menstrual discomfort and lactation support; preparations for pharmaceutical and medicinal use, namely, medicinal, sanitary and pharmaceutical oils other than essential oils and creams for medical use for stretch mark prevention and relief of muscle soreness; balms for medical use; gels, creams, lotions, and body oils for medical use, namely, anti-inflammatory gels for postpartum muscle relief, medicinal, sanitary and pharmaceutical lotions and oils other than essential oils for prevention and treatment of stretch marks, and soothing gels in the nature of medicinal gels, sanitary gels, pharmaceutical gels, anti-itching gels, anti-inflammatory gels and gels for dermatological use; preparations for topical treatment of wounds and scars, namely, pharmaceutical preparations for wounds; preparations, including gels, for the treatment of wounds and soreness arising in connection to breastfeeding, namely, pharmaceutical preparations for wounds, hemostatic gel matrix preparations for treating wounds, preparations for the relief of pain; absorbent articles for personal hygiene, namely, tampons, sanitary bandages in the nature of post-partum menstruation bandages, post-partum bandages for dressings, post-partum bandages for skin wounds, menstruation bandages, bandages for skin wounds, surgical bandages, menstruation pads, pantyliners, and menstruation and sanitary knickers; intimate cleansers, washes and soaps for medical purposes, namely, vaginal washes for medical purposes, medicated soaps, medicated bath soaps in liquid, solid or gel form; nursing pads; adhesive skin patches for medical use, namely, adhesive nipple patches for medical purposes, adhesive bandages in the form of patches; sanitary wear, namely, sanitary knickers, sanitary pants; pregnancy testing preparations for home use; ovulation test kits for home use; homeopathic medicines for use in the treatment of breastfeeding-related engorgement and discomfort; sanitary, hygienic and disinfecting products for medical purposes, namely, sanitary preparations for medical use, disinfectants for hygienic purposes, disinfecting handwash; materials for dressings, namely, medical dressings, wound dressings, self-adhesive dressings; plasters for medical purposes; patches and plasters with preparations for treatment of wounds and scars, namely, silicone sheets impregnated with medicated gels for the treatment of wounds and scars and pads for nipple soothing in the nature of breast pads; nipple pads in the nature of breast pads for cooling and for treating nipple wounds and soreness; medicated soaps and sanitising soaps and detergents, namely, antibacterial soaps, intimate washes in the nature of vaginal washes for medical purposes; antibacterial soap; disinfectant soapACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 1, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Sep 1, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 14, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 14, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 8, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 17, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 16, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 16, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 16, 2026ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Jun 12, 2026GNS1NOTIFICATION OF SUBSEQUENT FINAL EMAILED—
Jun 12, 2026GNCFCONTINUATION OF FINAL REFUSAL E-MAILED—
Jun 12, 2026CNCFACTION CONTINUING A FINAL - COMPLETED—
Jun 4, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jun 3, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 3, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 3, 2026ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
May 18, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
May 18, 2026OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Dec 13, 2025GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Dec 13, 2025GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Dec 13, 2025CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Dec 10, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 10, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 10, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 5, 2025RFNTREFUSAL PROCESSED BY IB—
Jun 13, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 12, 2025RFRRREFUSAL PROCESSED BY MPU—
Mar 30, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 29, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 27, 2025DOCKASSIGNED TO EXAMINER—
Dec 31, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 31, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 26, 2024LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Dec 19, 2024REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance